Table 2 . Multivariable analysis of confounding effect to combination antiviral treatment with favipiravir in COVID-19 patients hospitalized within 4 days of symptom onset and composite poor outcome (defined as at least one of the poor outcomes: requiring high-flow oxygen therapy, being intubated with mechanical ventilation, admission to ICU, or death).